One researcher discusses the implications of the recent plague outbreak in Madagascar, and what public health officials might be able to learn from it. (New England Journal of Medicine)
A new supplement in the Journal of Infectious Diseases argues that Zika is not going away, and there may be reasons to believe it could reemerge as a more aggressive pandemic. An introductory article co-written by NIAID Director Anthony Fauci, MD, addresses the disease’s most pressing research problems.
Could a class of drugs mainly used to treat rheumatoid arthritis hold promise for helping to control HIV infection? (PLOS Pathogens)
A new assay that could determine the difference between new and long-standing HIV infections might have implications for public health. (Journal of Clinical Investigation Insight)
Nigeria’s five-month cholera outbreak is over, says the World Health Organization, which credits an oral cholera vaccine campaign for helping to contain it.
Speaking of vaccination campaigns, an African city was able to reduce rabies transmission to humans through mass vaccination of dogs. (Science Translational Medicine)
Researchers are trying to deconstruct Escherichia coli bacteria, in order to find new ways of killing it. (Molecular Microbiology)
A review published in the British Journal of Pharmacology suggests that research into bacteriophages are key to combatting antimicrobial resistance.